Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Real-World Evidence Observational Study of VenusP-ValveTM System in the Treatment of Patients with Native RVOT Dysfunction

NCT05835349 is registered in ClinicalTrials.gov with Venus MedTech (HangZhou) Inc. as lead sponsor.

NCT NCT05835349
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05835349 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Real-World Evidence Observational Study of VenusP-ValveTM System in the Treatment of Patients with Native RVOT Dysfunction
Lead sponsor
Venus MedTech (HangZhou) Inc.
Phase
Observational
Overall status
Recruiting
Start date
August 26, 2024
Completion date
December 31, 2032
Enrollment
200 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

right ventricular outflow tract dysfunction